TY - JOUR AU - Michael, M. D. PY - 2014 DA - 2014// TI - Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics JO - Eur J Health Econ VL - 15 UR - https://doi.org/10.1007/s10198-014-0603-7 DO - 10.1007/s10198-014-0603-7 ID - Michael2014 ER - TY - JOUR AU - Avitan, A. K. AU - Schwartz, D. AU - Greenberg, D. AU - Friger, M. AU - Vardy, H. AU - Sarid, O. AU - Slonim-Nevo, V. AU - Odes, S. PY - 2016 DA - 2016// TI - The impact of inflammatory bowel disease on work productivity: comparison of a real-world sample of patients with Crohn’s disease and ulcerative colitis JO - Value Health VL - 19 UR - https://doi.org/10.1016/j.jval.2016.09.956 DO - 10.1016/j.jval.2016.09.956 ID - Avitan2016 ER - TY - JOUR AU - Kornbluth, A. AU - Sachar, D. B. PY - 2010 DA - 2010// TI - Ulcerative colitis practice guidelines in adults: American college of gastroenterology, practice parameters committee JO - Am J Gastroenterol VL - 105 UR - https://doi.org/10.1038/ajg.2009.727 DO - 10.1038/ajg.2009.727 ID - Kornbluth2010 ER - TY - JOUR AU - Danese, S. AU - Fiocchi, C. PY - 2011 DA - 2011// TI - Medical progress in ulcerative colitis—review article JO - N Engl J Med VL - 365 UR - https://doi.org/10.1056/NEJMra1102942 DO - 10.1056/NEJMra1102942 ID - Danese2011 ER - TY - JOUR AU - Allen, P. B. AU - Lindsay, H. AU - Tham, T. C. PY - 2010 DA - 2010// TI - How do patients with inflammatory bowel disease want their biological therapy administered? JO - BMC Gastroenterol VL - 10 UR - https://doi.org/10.1186/1471-230X-10-1 DO - 10.1186/1471-230X-10-1 ID - Allen2010 ER - TY - STD TI - REMICADE® (infliximab) is first biologic approved in European Union to treat ulcerative colitis. Evaluate, Editor. 2006. https://www.ptcommunity.com/news/20060309/remicade-approval-marks-first-biologic-therapy-treat-ulcerative-colitis-european-union. UR - https://www.ptcommunity.com/news/20060309/remicade-approval-marks-first-biologic-therapy-treat-ulcerative-colitis-european-union ID - ref6 ER - TY - JOUR AU - Cohen, R. PY - 2010 DA - 2010// TI - Systematic review: the costs of ulcerative colitis in Western countries JO - Aliment Pharmacol Ther VL - 31 UR - https://doi.org/10.1111/j.1365-2036.2010.04234.x DO - 10.1111/j.1365-2036.2010.04234.x ID - Cohen2010 ER - TY - JOUR AU - Lindsay, J. PY - 2015 DA - 2015// TI - Systematic review: the financial burden of surgical complications in patients with ulcerative colitis JO - Aliment Pharmacol Ther VL - 41 UR - https://doi.org/10.1111/apt.13197 DO - 10.1111/apt.13197 ID - Lindsay2015 ER - TY - JOUR AU - Annemans, L. AU - Aristides, M. AU - Kubin, M. PY - 2007 DA - 2007// TI - Real-life data: a growing need JO - ISPOR Connections VL - 13 ID - Annemans2007 ER - TY - JOUR AU - Kawalec, P. PY - 2016 DA - 2016// TI - Indirect costs of inflammatory bowel diseases: Crohn’s disease and ulcerative colitis. A systematic review JO - Arch Med Sci VL - 12 UR - https://doi.org/10.5114/aoms.2016.59254 DO - 10.5114/aoms.2016.59254 ID - Kawalec2016 ER - TY - JOUR AU - Nguyen, G. C. AU - Tuskey, A. AU - Dassopoulos, T. AU - Harris, M. L. AU - Brant, S. R. PY - 2007 DA - 2007// TI - Rising hospitalization rates for inflammatory bowel disease in the United States between 1998 and 2004 JO - Inflamm Bowel Dis VL - 13 UR - https://doi.org/10.1002/ibd.20250 DO - 10.1002/ibd.20250 ID - Nguyen2007 ER - TY - BOOK AU - Thompson, M. PY - 2012 DA - 2012// TI - A framework to facilitate the use of systematic reviews and meta-analyses in the design of primary research studies ID - Thompson2012 ER - TY - JOUR AU - Moher, D. PY - 2009 DA - 2009// TI - Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement JO - PLoS Med VL - 6 UR - https://doi.org/10.1371/journal.pmed.1000097 DO - 10.1371/journal.pmed.1000097 ID - Moher2009 ER - TY - JOUR AU - Kawalec, P. PY - 2017 DA - 2017// TI - Disease activity, quality of life, and indirect costs of ulcerative colitis in Poland JO - Prz Gastroenterol VL - 12 UR - https://doi.org/10.1007/s11377-016-0125-1 DO - 10.1007/s11377-016-0125-1 ID - Kawalec2017 ER - TY - JOUR AU - Valk, M. E. PY - 2016 DA - 2016// TI - Evolution of costs of inflammatory bowel disease over two years of follow-up JO - PLoS One VL - 11 UR - https://doi.org/10.1371/journal.pone.0142481 DO - 10.1371/journal.pone.0142481 ID - Valk2016 ER - TY - JOUR AU - Malinowski, K. P. AU - Kawalec, P. P. AU - Moćko, P. PY - 2016 DA - 2016// TI - Indirect costs of absenteeism due to rheumatoid arthritis, psoriasis, multiple sclerosis, insulin-dependent diabetes mellitus, and ulcerative colitis in 2012: a study based on real-life data from the social insurance institution in Poland JO - Expert Rev Pharmacoecon Outcomes Res VL - 16 UR - https://doi.org/10.1586/14737167.2016.1085802 DO - 10.1586/14737167.2016.1085802 ID - Malinowski2016 ER - TY - JOUR AU - Aldeguer, X. AU - Sicras-Mainar, A. PY - 2016 DA - 2016// TI - Costs of ulcerative colitis from a societal perspective in a regional health care area in Spain: a database study JO - Gastroenterol Hepatol (English Edition) VL - 39 UR - https://doi.org/10.1016/j.gastre.2016.01.002 DO - 10.1016/j.gastre.2016.01.002 ID - Aldeguer2016 ER - TY - JOUR AU - Cohen, R. PY - 2015 DA - 2015// TI - Direct and indirect healthcare resource utilization and costs associated with ulcerative colitis in a privately-insured employed population in the US JO - J Med Econ VL - 18 UR - https://doi.org/10.3111/13696998.2015.1021353 DO - 10.3111/13696998.2015.1021353 ID - Cohen2015 ER - TY - JOUR AU - Valk, M. E. PY - 2014 DA - 2014// TI - Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study JO - Gut VL - 63 UR - https://doi.org/10.1136/gutjnl-2012-303376 DO - 10.1136/gutjnl-2012-303376 ID - Valk2014 ER - TY - JOUR AU - Meek, P. D. PY - 2013 DA - 2013// TI - Tu1112 direct and indirect cost burden of ulcerative colitis: a matched analysis of healthcare costs, absenteeism, and short term disability costs in US patients with and without ulcerative colitis JO - Gastroenterology VL - 144 UR - https://doi.org/10.1016/S0016-5085(13)62828-0 DO - 10.1016/S0016-5085(13)62828-0 ID - Meek2013 ER - TY - BOOK AU - Cohen PY - 2012 DA - 2012// TI - Direct and indirect utilization and costs associated with ulcerative colitis ID - Cohen2012 ER - TY - JOUR AU - Kostic, M. PY - 2015 DA - 2015// TI - Costs of Inflamatory bowel disease (Crohns disease and ulcerative colitis) in Serbia JO - Value Health VL - 18 UR - https://doi.org/10.1016/j.jval.2015.09.2194 DO - 10.1016/j.jval.2015.09.2194 ID - Kostic2015 ER - TY - JOUR AU - Valk, M. PY - 2012 DA - 2012// TI - OP09 Anti TNF-α therapy is a major cost driver in inflammatory bowel disease: Results from the COIN study JO - J Crohns Colitis VL - 6 UR - https://doi.org/10.1016/S1873-9946(12)60010-5 DO - 10.1016/S1873-9946(12)60010-5 ID - Valk2012 ER - TY - JOUR AU - Cannon, M. D. PY - 2011 DA - 2011// TI - The individual financial burden of inflammatory bowel disease; the economic colitis JO - Gastroenterology VL - 140 ID - Cannon2011 ER - TY - JOUR AU - Gibson, T. B. PY - 2008 DA - 2008// TI - The direct and indirect cost burden of Crohn’s disease and ulcerative colitis JO - J Occup Environ Med VL - 50 UR - https://doi.org/10.1097/JOM.0b013e318181b8ca DO - 10.1097/JOM.0b013e318181b8ca ID - Gibson2008 ER - TY - BOOK AU - Hellström, P. M. AU - Stålhammar, J. AU - Beydogan AU - Huetson AU - Skup, M. AU - Agréus PY - 2017 DA - 2017// TI - Indirect burden of patients with moderate inflammatory bowel disease in Uppsala County Council, Sweden: a retrospective study using real-world data ID - Hellström2017 ER - TY - BOOK AU - Neovius, M. AU - Blomqvist, P. AU - Granath, F. AU - Ekbom, A. AU - Smedby, K. E. PY - 2011 DA - 2011// TI - Sick leave and disability pension in the Swedish ulcerative colitis population: nationwide cohort study ID - Neovius2011 ER - TY - JOUR AU - Stark, R. AU - König, H. -. H. AU - Leidl, R. PY - 2006 DA - 2006// TI - Costs of inflammatory bowel disease in Germany JO - Pharmacoeconomics VL - 24 UR - https://doi.org/10.2165/00019053-200624080-00006 DO - 10.2165/00019053-200624080-00006 ID - Stark2006 ER - TY - JOUR AU - Valk, M. E. PY - 2015 DA - 2015// TI - Comparison of costs and quality of life in ulcerative colitis patients with an ileal pouch–anal anastomosis, ileostomy and anti-TNFα therapy JO - J Crohn's Colitis VL - 9 UR - https://doi.org/10.1093/ecco-jcc/jjv134 DO - 10.1093/ecco-jcc/jjv134 ID - Valk2015 ER - TY - JOUR AU - Bodger, K. PY - 2014 DA - 2014// TI - Medical resource utilization and associated costs in patients with ulcerative colitis in the UK: a chart review analysis JO - Eur J Gastroenterol Hepatol VL - 26 UR - https://doi.org/10.1097/01.meg.0000435545.49133.cd DO - 10.1097/01.meg.0000435545.49133.cd ID - Bodger2014 ER - TY - JOUR AU - Hillson, E. PY - 2008 DA - 2008// TI - Health care expenditures in ulcerative colitis: the perspective of a self-insured employer JO - J Occup Environ Med VL - 50 UR - https://doi.org/10.1097/JOM.0b013e31816fd663 DO - 10.1097/JOM.0b013e31816fd663 ID - Hillson2008 ER - TY - BOOK AU - Lo, B. PY - 2019 DA - 2019// TI - Direct and indirect costs of inflammatory bowel disease: ten years of follow up in a Danish population-based inception cohort ID - Lo2019 ER -